Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Welch

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|June 3, 2014
A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: a study of the Princess Margaret, Chicago and California ConsortiaVincent Castonguay, Stephanie Lheureux, Stephen Welch, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2012
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancerDaniel J Renouf, Stephen Welch, Malcolm J Moore, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer CentresGautham Nair, Morgan Black, Kathie Baer, et al.
Hepatobiliary Surgery and Nutrition|June 28, 2017
Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference reviewKerollos N Wanis, Karen Pineda-Solis, Mauro E Tun-Abraham, et al.
The New Phytologist|June 18, 2015
Modeling development and quantitative trait mapping reveal independent genetic modules for leaf size and shapeRobert L Baker, Wen Fung Leong, Marcus T Brock, et al.
Frontiers in Oncology|July 24, 2023
Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratoryPratibha Bhai, Jacob Turowec, Stephanie Santos, et al.
JAMA Oncology|June 30, 2018
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical TrialVirginia F Borges, Cristiano Ferrario, Nathalie Aucoin, et al.
European Journal of Human Genetics : EJHG|July 18, 2013
Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer careFiona A Miller, Robin Z Hayeems, Jessica P Bytautas, et al.
British Journal of Clinical Pharmacology|January 19, 2023
Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patientsYong Jin Lim, Steven G Xiu, M Sara Kuruvilla, et al.
Oral Oncology|February 9, 2019
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patientsWendy A Teft, Eric Winquist, Anthony C Nichols, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|June 3, 2014
A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: a study of the Princess Margaret, Chicago and California ConsortiaVincent Castonguay, Stephanie Lheureux, Stephen Welch, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2012
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancerDaniel J Renouf, Stephen Welch, Malcolm J Moore, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer CentresGautham Nair, Morgan Black, Kathie Baer, et al.
Hepatobiliary Surgery and Nutrition|June 28, 2017
Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference reviewKerollos N Wanis, Karen Pineda-Solis, Mauro E Tun-Abraham, et al.
The New Phytologist|June 18, 2015
Modeling development and quantitative trait mapping reveal independent genetic modules for leaf size and shapeRobert L Baker, Wen Fung Leong, Marcus T Brock, et al.
Frontiers in Oncology|July 24, 2023
Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratoryPratibha Bhai, Jacob Turowec, Stephanie Santos, et al.
JAMA Oncology|June 30, 2018
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical TrialVirginia F Borges, Cristiano Ferrario, Nathalie Aucoin, et al.
European Journal of Human Genetics : EJHG|July 18, 2013
Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer careFiona A Miller, Robin Z Hayeems, Jessica P Bytautas, et al.
British Journal of Clinical Pharmacology|January 19, 2023
Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patientsYong Jin Lim, Steven G Xiu, M Sara Kuruvilla, et al.
Oral Oncology|February 9, 2019
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patientsWendy A Teft, Eric Winquist, Anthony C Nichols, et al.
Pageof 8